Vesicles, generally defined as self-assembled structures formed by single or multiple
concentric bilayers that surround an aqueous core, have been widely used for biomedical …

There is currently no licensed vaccine for brucellosis in humans. Available animal vaccines
may cause disease and are considered unsuitable for use in humans. However, the …

Prophylactic vaccines have evolved from traditional whole-cell vaccines to safer subunit
vaccines. However, subunit vaccines still face problems, such as poor immunogenicity and …

Recently, advances in pharmaceutical research is focused on new delivery systems utilizing
new devices to achieve modification of delivery time, targeting, as well as improve the in vivo …

Vaccine adjuvants are compounds that enhance host immune responses to co‐
administered antigens in vaccines. Vaxjo is a web‐based central database and analysis …

In this review, we discuss recent developments in multicompartment systems commonly
referred to as vesosomes, as well as their method of preparation, surface modifications, and …

Background/Objectives In spite of all the research effort for developing new vaccines against
brucellosis, it remains unclear whether these new vaccine technologies will in fact become …

Aims There are around 24 distinct lipid vesicles described in the literature that are similar to
vesicular systems such as liposomes. Liposome-like structures are formed by combining …

Successful colonization of the mucosal epithelial cells is the key early step for
Campylobacter jejuni (C. jejuni) pathogenesis in humans. A set of Surface Exposed …

Acinetobacter baumannii is one of the most successful pathogens causing nosocomial
infections and has significantly multidrug-resistant. So far, there are no certain treatments to …